Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Spine Metastases and Primary Spine Tumors

NCT01347307 is registered in ClinicalTrials.gov with Mercy Research as lead sponsor.

NCT NCT01347307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01347307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Spine Metastases and Primary Spine Tumors
Lead sponsor
Mercy Research
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2008
Completion date
September 30, 2017
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous malformations, benign spinal tumors, chordoma, meningioma, neurofibroma, paragangliomas, schwannoma, spinal metastases, vertebral metastases